Report Summary
Eternity Insights has published a new study on Global Erectile Dysfunction Drugs Market focusing on key segments as by Type (Sildenafil, Tadalafil, Others), by Application (Hospital Pharmacies, Private Clinics, Retail Pharmacies, E-Commerce (B2B), E-Commerce (B2C)), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Erectile Dysfunction Drugs Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Erectile Dysfunction Drugs Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Erectile Dysfunction Drugs Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Erectile Dysfunction Drugs Market Segmentation:
Erectile Dysfunction Drugs Market, By Type
- Sildenafil
- Tadalafil
- Others
Erectile Dysfunction Drugs Market, By Application
- Hospital Pharmacies
- Private Clinics
- Retail Pharmacies
- E-Commerce (B2B)
- E-Commerce (B2C)
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Erectile Dysfunction Drugs market in terms of demand generation. The Erectile Dysfunction Drugs market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Erectile Dysfunction Drugs market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Erectile Dysfunction Drugs Market Taxonomy:
To learn more about this report
Global Erectile Dysfunction Drugs Market Competitive Landscape
The global Erectile Dysfunction Drugs market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Eli Lilly
- Pfizer
- Bayer
- BaiYunShan General Factory
- S.K. Chemicals
- Teva Pharma
- Dong-A ST
- Metuchen Pharma
- Seoul Pharma
- CSBIO.
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Sildenafil, Tadalafil, Others |
| By Application Outlook |
Hospital Pharmacies, Private Clinics, Retail Pharmacies, E-Commerce (B2B), E-Commerce (B2C) |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO. |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
1 Erectile Dysfunction Drugs Market Overview 1
1.1 Erectile Dysfunction Drugs Product Overview 1
1.2 Erectile Dysfunction Drugs Market Segment by Type 3
1.2.1 Sildenafil 4
1.2.2 Tadalafil 5
1.2.3 Others 6
1.3 Global Erectile Dysfunction Drugs by Type 7
1.3.1 Global Erectile Dysfunction Drugs Sales and Growth by Type 8
1.3.2 Global Erectile Dysfunction Drugs Sales Market Share by Type 8
1.3.3 Global Erectile Dysfunction Drugs Revenue Market Share by Type 10
1.3.4 Global Erectile Dysfunction Drugs Price by Type 11
1.4 North America Erectile Dysfunction Drugs by Type 11
1.5 Europe Erectile Dysfunction Drugs by Type 12
1.6 Asia-Pacific Erectile Dysfunction Drugs by Type 13
1.7 South America Erectile Dysfunction Drugs by Type 14
1.8 Middle East and Africa Erectile Dysfunction Drugs by Type 15
2 Global Erectile Dysfunction Drugs Market Competition by Company 17
2.1 Global Erectile Dysfunction Drugs Sales Market Share by Company (2018-2019) 17
2.2 Global Erectile Dysfunction Drugs Revenue and Share by Company (2018-2019) 19
2.3 Global Erectile Dysfunction Drugs Price by Company 20
2.4 Global Top Company Erectile Dysfunction Drugs, Headquarters, Established Date and Product Types 21
2.5 Erectile Dysfunction Drugs Market Competitive Situation and Trends 22
2.5.1 Erectile Dysfunction Drugs Market Concentration Rate 22
2.5.2 Global Erectile Dysfunction Drugs Market Share of Top 3 and Top 5 Company 23
2.5.3 Mergers & Acquisitions, Expansion 24
3 Analysis of Erectile Dysfunction Drugs Industry Key Manufacturers 33
3.1 Eli Lilly and Company 33
3.1.1 Company Profile 33
3.1.2 Product Information 34
3.1.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 34
3.2 Pfizer 35
3.2.1 Company Profile 35
3.2.2 Product Information 36
3.2.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 37
3.3 Bayer 38
3.3.1 Company Profile 38
3.3.2 Product Information 39
3.3.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 40
3.4 BaiYunShan General Factory 41
3.4.1 Company Profile 41
3.4.2 Product Information 42
3.4.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 43
3.5 S.K. Chemicals 43
3.5.1 Company Profile 43
3.5.2 Product Information 44
3.5.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 45
3.6 Teva Pharma 45
3.6.1 Company Profile 45
3.6.2 Product Information 46
3.6.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 47
3.7 Dong-A ST 48
3.7.1 Company Profile 48
3.7.2 Product Information 49
3.7.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 49
3.8 Metuchen Pharmaceuticals 50
3.8.1 Company Profile 50
3.8.2 Product Information 51
3.8.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 51
3.9 Seoul Pharma 52
3.9.1 Company Profile 52
3.9.2 Product Information 53
3.9.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 53
3.10 CSBIO 54
3.10.1 Company Profile 54
3.10.2 Product Information 55
3.10.3 Sales, Price, Revenue, Gross Margin and Revenue Market Share 55
4 Erectile Dysfunction Drugs Status and Outlook by Regions 56
4.1 Global Erectile Dysfunction Drugs Market Status and Outlook by Regions 56
4.1.1 Global Erectile Dysfunction Drugs Market Size and CAGR by Regions 56
4.1.2 North America 56
4.1.3 Asia-Pacific 57
4.1.4 Europe 58
4.1.5 South America 59
4.1.6 Middle East and Africa 60
4.2 Global Erectile Dysfunction Drugs Sales and Revenue by Regions 61
4.2.1 Global Erectile Dysfunction Drugs Sales Market Share by Regions (2014-2019) 61
4.2.2 Global Erectile Dysfunction Drugs Revenue Market Share by Regions (2014-2019) 63
4.3 North America Erectile Dysfunction Drugs Sales and Revenue 66
4.3.1 North America Erectile Dysfunction Drugs Sales by Countries 66
4.3.2 United States 67
4.3.3 Canada 68
4.3.4 Mexico 69
4.4 Europe Erectile Dysfunction Drugs Sales and Revenue 70
4.4.1 Europe Erectile Dysfunction Drugs Sales by Countries 71
4.4.2 Germany 72
4.4.3 UK 73
4.4.4 France 74
4.4.5 Italy 75
4.4.6 Russia 76
4.5 Asia-Pacific Erectile Dysfunction Drugs Sales and Revenue 77
4.5.1 Asia-Pacific Erectile Dysfunction Drugs Sales by Countries 77
4.5.2 China 78
4.5.3 Japan 79
4.5.4 Korea 80
4.5.5 Southeast Asia 81
4.5.6 India 82
4.6 South America Erectile Dysfunction Drugs Sales and Revenue 83
5 Erectile Dysfunction Drugs by Application 85
5.1 Erectile Dysfunction Drugs Segment by Application 85
5.1.1 Hospital Pharmacies 85
5.1.2 Private Clinics 86
5.1.3 Retail Pharmacies 86
5.1.4 E-Commerce (B2B) 87
5.1.5 E-Commerce (B2C) 87
5.2 Global Erectile Dysfunction Drugs Product Segment by Application 88
5.2.1 Global Erectile Dysfunction Drugs Sales by Application 88
5.2.2 Global Erectile Dysfunction Drugs Sales and Market Share by Application (2014-2019) 88
5.3 North America Erectile Dysfunction Drugs by Application 89
5.4 Europe Erectile Dysfunction Drugs by Application 91
5.5 Asia-Pacific Erectile Dysfunction Drugs by Application 92
5.6 South America Erectile Dysfunction Drugs by Application 93
5.7 Middle East and Africa Erectile Dysfunction Drugs by Application 94
6 Global Erectile Dysfunction Drugs Market Forecast 96
6.1 Global Erectile Dysfunction Drugs Sales, Revenue Forecast (2019-2025) 96
6.1.1 Global Erectile Dysfunction Drugs Sales and Growth Rate Forecast (2019-2025) 96
6.1.2 Global Erectile Dysfunction Drugs Revenue and Growth Rate Forecast (2019-2025) 97
6.2 Global Erectile Dysfunction Drugs Forecast by Regions 97
6.2.1 North America Erectile Dysfunction Drugs Sales and Revenue Forecast (2019-2025) 99
6.2.2 Europe Erectile Dysfunction Drugs Sales and Revenue Forecast (2019-2025) 101
6.2.3 Asia-Pacific Erectile Dysfunction Drugs Sales and Revenue Forecast (2019-2025) 103
6.2.4 South America Erectile Dysfunction Drugs Sales and Revenue Forecast (2019-2025) 105
6.2.5 Middle East and Africa Erectile Dysfunction Drugs Sales and Revenue Forecast (2019-2025) 107
6.3 Erectile Dysfunction Drugs Forecast by Type 108
6.3.1 Global Erectile Dysfunction Drugs Sales and Revenue Forecast by Type (2019-2025) 108
6.3.2 Sildenafil Growth Forecast 109
6.3.3 Tadalafil Growth Forecast 110
6.4 Erectile Dysfunction Drugs Forecast by Application 110
6.4.1 Global Erectile Dysfunction Drugs Sales Forecast by Application (2019-2025) 110
6.4.2 Global Erectile Dysfunction Drugs in Hospital Pharmacies Forecast 112
7 Erectile Dysfunction Drugs Upstream Raw Materials 113
7.1 Erectile Dysfunction Drugs Key Raw Materials 113
7.1.1 Key Raw Materials 113
7.1.2 Raw Materials Key Suppliers 113
7.2 Manufacturing Cost Structure 114
7.2.1 Raw Materials 114
7.2.2 Labor Cost 114
7.2.2.1 USA Labor Cost Analysis 115
7.2.2.2 Europe Labor Costs Analysis 117
7.2.2.3 Asia Labor Costs Analysis 119
7.2.3 Other Costs Analysis 121
7.2.3.1 USA Cost of Electricity Analysis 122
7.2.3.2 USA Water Cost Analysis 122
7.2.3.3 Europe Cost of Electricity Analysis 123
7.2.3.4 Europe Water Cost Analysis 124
7.2.3.5 China Cost of Electricity Analysis 124
7.2.3.6 China Water Cost Analysis 125
7.3 Economic/Political Environmental Change 125
7.4 Erectile Dysfunction Drugs Industrial Chain Analysis 134
8 Marketing Strategy Analysis, Distributors 135
8.1 Sales Channel 135
8.2 Distributors 137
8.3 Downstream Customers 139
9 Research Findings and Conclusion 141
10 Appendix 142
10.1 Methodology/Research Approach 142
10.2 Research Programs/Design 142
10.2.1 Market Size Estimation 143
10.2.2 Market Breakdown and Data Triangulation 144
10.3 Data Source 146
10.3.1 Secondary Sources 146
10.3.2 Primary Sources 147
10.4 Author List 148
10.5 Disclaimer 149
